153 related articles for article (PubMed ID: 8094550)
1. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
Polak MJ; Drummond WH
Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550
[TBL] [Abstract][Full Text] [Related]
2. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
Polak MJ; Taylor DA
Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
4. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
[TBL] [Abstract][Full Text] [Related]
5. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Christie MI; Smith GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
[TBL] [Abstract][Full Text] [Related]
7. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
Grenader A; Healy DP
J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
Zhao RR; Wang PH; Zhang WF; Fennell WH
Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
[TBL] [Abstract][Full Text] [Related]
10. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
11. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
Polak MJ; Kennedy LA; Drummond WH
Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520
[TBL] [Abstract][Full Text] [Related]
13. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
14. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
Clark KL; Robertson MJ; Drew GM
J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary and systemic vascular effects of SKF-82526-J, a new specific peripheral dopamine receptor agonist, in unanesthetized neonatal lambs.
Drummond WH; Williams BJ; Kelley KC
Dev Pharmacol Ther; 1983; 6(1):1-8. PubMed ID: 6132785
[TBL] [Abstract][Full Text] [Related]
16. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
Wang YX; Gellai M; Brooks DP
Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
[TBL] [Abstract][Full Text] [Related]
17. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.
Bakris GL; Weber RR; Nelson K; Elliott WJ; Kaplan E; Murphy MB
Miner Electrolyte Metab; 1988; 14(6):343-6. PubMed ID: 2906737
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
[TBL] [Abstract][Full Text] [Related]
20. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
